Anti-Mycobacterium abscessus activity of tuberculosis F-ATP synthase inhibitor GaMF1
New drug targets and molecules with bactericidal activity are needed against the respiratory mycobacterial pathogen Mycobacterium abscessus (Mab). Employing a lead repurposing strategy, the anti-tuberculosis compound GaMF1 was tested against Mab. Whole cell- and ATP synthesis assays demonstrated tha...
| Hauptverfasser: | , , |
|---|---|
| Weitere Verfasser: | |
| Format: | Journal Article |
| Sprache: | English |
| Veröffentlicht: |
2022
|
| Schlagworte: | |
| Online Zugang: | https://hdl.handle.net/10356/163132 |